In this study, we compared the usefulness of the AFP and the MK promoters for HCC treatment by examining the frequency of MK and AFP expression in human HCC specimens and the transcriptional activity of the promoters in HCC cell lines. The gene discussed is AFP; the disease is hepatocellular carcinoma.